MiR-9 enhances the sensitivity of A549 cells to cisplatin by inhibiting autophagy

Biotechnol Lett. 2017 Jul;39(7):959-966. doi: 10.1007/s10529-017-2325-2. Epub 2017 Mar 23.

Abstract

Objectives: To demonstrate that miR-9 inhibits autophagy by down-regulating Beclin1 and thus enhances the sensitivity of A549 cells to cisplatin.

Results: MiR-9 inhibited Beclin1 expression by binding to its 3'UTR. The inhibition decreased the cisplatin-induced autophagy in A549 cells, evidenced by the decreased expression of LC3II and GFP-LC3 puncta and the increased expression of P62. Upregulation of miR-9 level enhanced the sensibility of A549 cells to cisplatin and increased the cisplatin-induced apoptosis. Overexpression of Beclin1 reversed above effects of miR-9 mimics, cisplatin-induced autophagy was increased and apoptosis was decreased.

Conclusions: MiR-9 inhibits autophagy via targeting Beclin1 3'UTR and thus enhances cisplatin sensitivity in A549 cells.

Keywords: A549 cells; Apoptosis; Autophagy; Beclin1; Cisplatin; MiR-9.

MeSH terms

  • A549 Cells
  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects
  • Autophagy / drug effects*
  • Beclin-1 / biosynthesis
  • Cell Survival / drug effects
  • Cisplatin / pharmacology*
  • Cross-Linking Reagents
  • Epithelial Cells / drug effects*
  • Gene Expression
  • Humans
  • MicroRNAs / metabolism*
  • Radiation-Sensitizing Agents

Substances

  • Antineoplastic Agents
  • BECN1 protein, human
  • Beclin-1
  • Cross-Linking Reagents
  • MIRN92 microRNA, human
  • MicroRNAs
  • Radiation-Sensitizing Agents
  • Cisplatin